2025 SPS Minneapolis | Operationalization of Tumor-Infiltrating Lymphocyte (TIL) Therapy

2025 SPS Minneapolis | Operationalization of Tumor-Infiltrating Lymphocyte (TIL) Therapy

Overview

NA

Target Audience

Pharmacists

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Spencer Lehmann, PharmD, BCOP

Date of Release

September 13th, 2025